Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

15,213 questions in 2,394 reviews

current versions
No studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Surgical thrombectomy vs pulse spray technique
Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Pharmacomechanical thrombolysis (Cragg® catheter) vs pulse spray technique
Failure · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Pharmacomechanical thrombolysis (Cragg® catheter) vs pulse spray technique
Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Pharmacomechanical thrombolysis (Cragg® catheter) vs pulse spray technique
Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Pharmacomechanical thrombolysis (Cragg® catheter) vs pulse spray technique
Death · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Surgical thrombectomy vs different types of endovascular interventions
Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Surgical thrombectomy vs different types of endovascular interventions
Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Surgical thrombectomy vs different types of endovascular interventions
Death · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Surgical thrombectomy vs pulse spray technique
Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Surgical thrombectomy vs pulse spray technique
Death · thrombosed haemodialysis arteriovenous fistulas and grafts
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane
no estimate extractedNRNo studies
Summary of findings for the main comparison: comprehensive care programmes vs usual care
Costs to the family · children with medical complexity
Comprehensive care programmes for children with medical complexity (2024) · Cochrane
no estimate extractedNRNo studies
Facilitated tucking / four‐handed care / gentle human touch vs standard care
Validated pain scales · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Familiar odour (breast milk smell) vs standard care
Validated pain scores · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Familiar odour (breast milk smell) vs standard care
Physiological indicators · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Familiar odour (breast milk smell) vs standard care
Behavioural indicators · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Familiar odour (breast milk smell) vs standard care
— · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
White noise vs standard care
Validated pain scores · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
White noise vs standard care
Physiological indicators · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
White noise vs standard care
Behavioural indicators · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
White noise vs standard care
— · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Facilitated tucking / four‐handed care / gentle human touch vs standard care
Physiological indicators · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Facilitated tucking / four‐handed care / gentle human touch vs standard care
Behavioural indicators · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Facilitated tucking / four‐handed care / gentle human touch vs standard care
— · neonates with mechanical ventilation
Non‐pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated… (2024) · Cochrane
no estimate extractedNRNo studies
Mindfulness‐based interventions (MBIs) vs active comparators
Clinical CVD events · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs active comparators
Well‐being · people at high risk of or with cardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs active comparators
Adverse events · people at high risk of or with cardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs active comparators
Smoking cessation · people at high risk of or with cardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs non‐active comparators
Clinical CVD events · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs non‐active comparators
Perceived stress · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs non‐active comparators
Well‐being · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs non‐active comparators
Adverse events · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Transcendental meditation (TM) vs non‐active comparators
Smoking cessation · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
Mindfulness‐based interventions (MBIs) vs active comparators
Adverse events · people at high risk of or withcardiovascular disease
Meditation for the primary and secondary prevention of cardiovascular disease (2024) · Cochrane
no estimate extractedNRNo studies
TG4010 added to chemotherapy vs chemotherapy alone
Survival rates at 5 years · adults with advanced non‐small cell lung cancer (NSCLC)
Therapeutic vaccines for advanced non‐small cell lung cancer (2024) · Cochrane
no estimate extractedNRNo studies
TG4010 added to chemotherapy vs chemotherapy alone
Health‐related quality of life · adults with advanced non‐small cell lung cancer (NSCLC)
Therapeutic vaccines for advanced non‐small cell lung cancer (2024) · Cochrane
no estimate extractedNRNo studies
Epidermal growth factor vs best supportive care
Progression‐free survival · adults with advanced non‐small cell lung cancer (NSCLC)
Therapeutic vaccines for advanced non‐small cell lung cancer (2024) · Cochrane
no estimate extractedNRNo studies
Metformin vs active control
Kidney failure · preventing the progression of CKD
Metformin for preventing the progression of chronic kidney disease (2024) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane
no estimate extractedNRNo studies
Ondansetron vs diphenhydramine (antihistamine)
Adverse events · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Ondansetron vs diphenhydramine (antihistamine)
Pain · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Enalapril ointment vs placebo
Adverse events · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Enalapril ointment vs placebo
Pain · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Massage therapy vs standard care
Adverse events · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Extracorporeal shock wave therapy vs sham
Adverse events · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Pulsed high‐intensity laser vs placebo laser
Adverse events · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Doxepin cream vs oral antihistamine
Pain · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Gabapentin vs cetirizine (antihistamine)
Pain · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Pregabalin vs cetirizine with pheniramine maleate (antihistamine)
Pain · people with postburn pruritus
Interventions for postburn pruritus (2024) · Cochrane
no estimate extractedNRNo studies
Anti‐CD52 mAb maintenance therapy vs observation
Overall survival – not reported · people with chronic lymphocytic leukaemia
Maintenance therapy for chronic lymphocytic leukaemia (2024) · Cochrane
no estimate extractedNRNo studies
Anti‐CD52 mAb maintenance therapy vs observation
Health‐related quality of life – not reported · people with chronic lymphocytic leukaemia
Maintenance therapy for chronic lymphocytic leukaemia (2024) · Cochrane
no estimate extractedNRNo studies